| Issue |
Title |
File |
| Vol 10, No 1 (2013) |
The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society) |
|
|
Chazova I.E., Chuchalin A.G., Zykov K.A., Ratova L.G.
|
| Vol 17, No 2 (2020) |
The effect of adherence with long-term PAP therapy on the psycho-emotional state of patients with obstructive sleep apnea syndrome |
(Rus)
|
|
Elfimova E.M., Mikhailova O.O., Khachatryan N.T., Starostin I.V., Litvin A.Y., Сhazova I.E.
|
| Vol 14, No 1 (2017) |
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension |
(Rus)
|
|
Elfimova E.M., Rvacheva A.V., Tripoten M.I., Pogorelova O.V., Balakhonova T.V., Zykov K.A., Litvin A.Y.
|
| Vol 13, No 4 (2016) |
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea |
(Rus)
|
|
Elfimova E.M., Zairova A.R., Andrievskaya M.V., Bogieva R.M., Rogoza A.N., Litvin A.Y.
|
| Vol 14, No 2 (2017) |
The effect of combined therapy on the properties of the vessel wall in patients at high risk of cardiovascular complications |
(Rus)
|
|
Blankova Z.N., Aslanyan N.S.
|
| Vol 11, No 2 (2014) |
The effectiveness of zofenopril in patients with cardiovascular disease |
(Rus)
|
|
Kukes V.G., Anikin G.S.
|
| Vol 10, No 4 (2013) |
The effects of climate in patients with arterial hypertension, including in combination with chronic obstructive pulmonary disease and/or bronchial asthma |
|
|
Chazova I.E., Ratova L.G., Dolgusheva Y.A., Nazarov B.M., Agapova O.Y., Sivakova O.A., Galitsin P.V., Rvacheva A.V., Kuznetsova T.V., Beilina V.B., Tkachev G.A., Kaznacheeva E.I., Zykov K.A.
|
| Vol 14, No 3 (2017) |
The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations |
(Rus)
|
|
Ostroumova O.D., Piksina G.F., Smolyarchuk E.A., Pavleeva E.E., Bondarets O.V.
|
| Vol 12, No 1 (2015) |
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome |
(Rus)
|
|
Skibickiy V.V., Fendrikova A.V., Skibickiy A.V., Syrotenko D.V.
|
| Vol 18, No 4 (2021) |
The efficiency of two-level electrovectorcardiographic diagnostics of left ventricular hypertrophy in the medical examination of urban and rural population |
(Rus)
|
|
Riabykina G.V., Vishniakova N.A., Fedorova V.S.
|
| Vol 12, No 2 (2015) |
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension |
(Rus)
|
|
Chazova E.E., Martyniuk T.V.
|
| Vol 12, No 3 (2015) |
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension |
(Rus)
|
|
Dadacheva Z.K., Belevskaya A.A., Saidova M.A., Danilov N.M., Martyniuk T.V., Chazova I.E.
|
| Vol 11, No 2 (2014) |
The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk |
(Rus)
|
|
Mordvinova E.V., Oschepkova E.V., Fedorovich A.A., Rogoza A.N.
|
| Vol 12, No 2 (2015) |
The hardness of the vessel wall in patients with arterial hypertension |
(Rus)
|
|
Ostroumova O.D., Kochetkov A.I., Kopchenov I.I., Guseva T.F., Bondarec O.V.
|
| Vol 11, No 3 (2014) |
The impact of fixed combination of amlodipine and perindopril (drug Prestance)on the mechanisms of heat adaptation in patients with arterial hypertension |
(Rus)
|
|
Ageev F.T., Smirnova M.D., Fofanova T.V., Svirida O.N., Mikhailov G.D., Revich B.A.
|
| Vol 6, No 4 (2009) |
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA) |
|
|
Mychka V.B., Zhernakova Y.V., Chazova I.E.
|
| Vol 15, No 2 (2018) |
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial |
(Rus)
|
|
Chazova I.E., Martynyuk T.V., Accetto R., Sirenko Y.N., Vincelj J., Widimsky J., Barbič-Žagar B., Arhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galjavich A.S., Rotar O.P., Haisheva L.A., Nedogoda S.V.
|
| Vol 14, No 3 (2017) |
The influence of Losartanum and Amlodipinum fixed combination use on cardiovascular complications risk factors seasonal variability in patients with arterial hypertension |
(Rus)
|
|
Smirnova M.D., Fofanova T.V., Ageev F.T., Blankova Z.N., Vicenia M.V., Barinova I.V.
|
| Vol 6, No 2 (2009) |
The intensive control of blood pressure: possibilities of the combined therapy. |
|
|
Andrushchishina T.B., Morozova T.E.
|
| Vol 6, No 2 (2009) |
The level of uric acid and its role at early stages of essential hypertension |
|
|
Oshchepkova E.V., Dmitriev V.A., Polovitkina O.V., Titov V.N.
|
| Vol 13, No 2 (2016) |
The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk |
(Rus)
|
|
Mordvinova E.V., Oshchepkova E.V., Fedorovich A.A., Zairova A.R., Pogorelova O.A., Tripoten M.I., Rogoza A.N.
|
| Vol 12, No 1 (2015) |
The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia |
(Rus)
|
|
Shishkova V.N.
|
| Vol 11, No 2 (2014) |
The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management |
(Rus)
|
|
Shishkova V.N.
|
| Vol 6, No 4 (2009) |
The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
|
|
Evdokimova A.G., Ol'khin V.A., Evdokimov V.V., Zolotareva E.V., Khadzegova A.B.
|
| Vol 16, No 4 (2019) |
The nature of the course of arterial hypertension in low-renin hyperaldosteronism |
(Rus)
|
|
Chikhladze N.M.
|
| Vol 14, No 3 (2017) |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
(Rus)
|
|
Chazova I.Y., Zhernakova Y.V., Blinova N.V., Rogoza A.N.
|
| Vol 10, No 1 (2013) |
The new widely discussed clinically significant aspects influence of β-blockers |
|
|
Arutyunov G.P.
|
| Vol 13, No 4 (2016) |
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome |
(Rus)
|
|
Blinova N.V., Zhernakova Y.V., Chazova I.E., Oshchepkova E.V.
|
| Vol 6, No 1 (2009) |
The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008 |
|
|
Chazova I.E., Ratova L.G., Chazova I.E., Ratova L.G.
|
| Vol 17, No 4 (2020) |
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension |
(Rus)
|
|
Pinchuk T.V., Orlova N.V.
|
| Vol 10, No 2 (2013) |
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension |
|
|
Tereshchenko S.N., Zhirov I.V.
|
| Vol 15, No 1 (2018) |
The place of intervention methods of treatment of patients with resistant hypertension in clinical practice |
(Rus)
|
|
Agaeva R.A., Danilov N.M., Sagaydak O.V., Chazova I.E.
|
| Vol 16, No 3 (2019) |
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus |
(Rus)
|
|
Zhernakova J.V., Chazova I.E., Blinova N.V.
|
| Vol 13, No 3 (2016) |
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan |
(Rus)
|
|
Zhernakova Y.V., Chazova I.E.
|
| Vol 13, No 1 (2016) |
The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic |
(Rus)
|
|
Nedogoda S.V., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Ledyaeva A.A., Chumachok E.V., Salasyuk A.S.
|
| Vol 10, No 4 (2013) |
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District |
|
|
Chazova I.E., Trubacheva I.A., Zhernakova Y.V., Oshchepkova E.V., Serebriakova V.N., Kaveshnikov V.S., Karpov R.S.
|
| Vol 11, No 4 (2014) |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
(Rus)
|
|
Zhernakova Y.V., Kaveshnikov V.S., Serebriakova V.N., Trubacheva I.A., Oshepkova Y.V., Balahonova T.V., Karpov R.S., Chazova I.Y.
|
| Vol 15, No 1 (2018) |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
(Rus)
|
|
Zhernakova Y.V., Chazova I.E., Oshchepkova E.V., Shalnova S.A., Konradi A.O., Rotar O.P., Yarovaya E.B., Shlyahto E.V., Boitsov S.A.
|
| Vol 12, No 3 (2015) |
The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study) |
(Rus)
|
|
Oshchepkova E.V., Dolgusheva I.A., Zhernakova I.V., Chazova I.E., Shal'nova S.A., Iarovaia E.B., Rotar' O.P., Konradi A.O., Boitsov S.A.
|
| Vol 15, No 1 (2018) |
The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies |
(Rus)
|
|
Klimova A.A., Ambatello L.G., Smolyakova E.V., Nistor S.Y., Zykov K.A., Chazova I.E.
|
| Vol 11, No 2 (2014) |
The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience |
(Rus)
|
|
Gilyarevsky S.R.
|
| Vol 15, No 3 (2018) |
The progression of carotid vascular remodeling risk factors in patients with arterial hypertension |
(Rus)
|
|
Pavlova O.S., Korobko I.Y., Nechesova T.A., Liventseva M.M., Zatoloka N.V., Kovsh E.V., Ogurtsova S.E., Mrochek A.G.
|
| Vol 12, No 2 (2015) |
The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions |
(Rus)
|
|
Samorodskaya I.V., Boitsov S.A.
|
| Vol 15, No 4 (2018) |
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm |
(Rus)
|
|
Sobolev A.V., Talabanov P.G., Ryabykina G.V., Kozhemyakina E.S.
|
| Vol 14, No 2 (2017) |
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension |
(Rus)
|
|
Chazova I.E., Martynyuk T.V., Accetto R., Sirenko Y., Vincelj J., JWidimsky J., Barbič-Žagar B., Arhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galjavich A.S., Rotar' O.P., Haisheva L.A., Nedogoda S.V.
|
| Vol 11, No 3 (2014) |
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve) |
(Rus)
|
|
Chazova I.Y.
|
| Vol 12, No 3 (2015) |
The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (AH patients survey) |
(Rus)
|
|
Leonova M.V., Belousov Y.B., Shteinberg L.L., Alimova E.E., Smirnova E.P., Belousov D.Y.
|
| Vol 12, No 1 (2015) |
The rise of cardiac biomarkers due to planned PCI and 1-year prognosis in patients with stable coronary artery disease and arterial hypertension |
(Rus)
|
|
Mironova O.Y.
|
| Vol 6, No 1 (2009) |
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan |
|
|
Baryshnikova G.A., Baryshnikova G.A.
|
| Vol 15, No 4 (2018) |
The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities |
(Rus)
|
|
Ostroumova O.D., Kochetkov A.I.
|
| Vol 13, No 1 (2016) |
The role of b-blockers in treatment of hypertension, according to Russian and European experts |
(Rus)
|
|
Ostroumova O.D., Fomina V.M., Shchukina G.N., Smoliarchuk E.A.
|
| Vol 12, No 1 (2015) |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
(Rus)
|
|
Zhernakova Y.V., Chazova I.E.
|
| Vol 13, No 3 (2016) |
The role of bisoprolol in the management of patients with arterial hypertension |
(Rus)
|
|
Nedogoda S.V.
|
| Vol 12, No 4 (2015) |
The role of risk factors and endothelium dysfunction in the pathogenesis of the high normal arterial preassure and clinical signs of the vegetative disturbances in children |
(Rus)
|
|
Maksimovich N.A.
|
| Vol 11, No 3 (2014) |
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects |
(Rus)
|
|
Gilyarevsky S.R.
|
| Vol 11, No 4 (2014) |
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF |
(Rus)
|
|
Rogoza A.N., Kaveshnikov V.S., Trubacheva I.A., Serebriakova V.N., Zairova A.R., Zhernakova Y.V., Oshepkova Y.V., Karpov R.S., Chazova I.Y.
|
| Vol 11, No 1 (2014) |
The telmisartan and amlodipine combination in the treatment of hypertension |
(Rus)
|
|
Shehyan G.G., Yalymov A.A., Schikota A.M., Zadionchenko V.S., Varentsov S.I.
|
| Vol 11, No 4 (2014) |
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders |
(Rus)
|
|
Zhernakov Y.V., Chazova I.Y.
|
| Vol 6, No 4 (2009) |
The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension |
|
|
Zagidullin N.S., Zagidullin S.Z.
|
| Vol 13, No 1 (2016) |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
(Rus)
|
|
Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E.
|
| Vol 11, No 1 (2014) |
The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS») |
(Rus)
|
|
Ostroumova O.D., Bondarets O.V., Guseva T.F.
|
| Vol 6, No 4 (2009) |
Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study) |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 6, No 4 (2009) |
Topical problems in the clinical application of -adrenoblockers |
|
|
Nebieridze D.V.
|
| Vol 11, No 4 (2014) |
Topical questions of beta-blockers application in clinical practice |
(Rus)
|
|
Nebieridze D.V.
|
| Vol 12, No 4 (2015) |
Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity |
(Rus)
|
|
Poteshkina N.G., Troshina A.A.
|
| Vol 10, No 2 (2013) |
Torasemide: additional benefits for postmenopausal women with arterial hypertension |
|
|
Tkacheva O.N., Runikhina N.K., Sharashkina N.V.
|
| Vol 12, No 3 (2015) |
Treatment of hypertension in overweight patients |
(Rus)
|
|
Kukes V.G., Anikin G.S., Andreevskaya E.M., Ashurkova E.A.
|
| Vol 14, No 1 (2017) |
Treatment of patients with high cardiovascular risk: a modern view on combined therapy |
(Rus)
|
|
Blankova Z.N., Aslanian N.S., Smolianinova N.G., Ageev F.T.
|
| Vol 12, No 1 (2015) |
Treatment with perindopril in patients with arterial hypertension: improving compliance |
(Rus)
|
|
Anikin G.S., Minina E.S., Andreevskaya E.M.
|
| Vol 8, No 1 (2011) |
Tyazhest' metabolicheskogo sindroma opredelyaetsya chislom ego komponentov. |
|
|
Zhernakova Y.V., Chazova I.E., Mychka V.B., Olimpieva S.P.
|
| Vol 5, No 1 (2008) |
Uluchshenie kontrolya arterial'noy gipertonii u lits s vysokim riskom razvitiya serdechno-sosudistykh oslozhneniy: vozmozhnosti ispol'zovaniya rezul'tatov programmy ARGUS-2 |
|
|
Kislyak O.A.
|
| Vol 16, No 4 (2019) |
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy |
(Rus)
|
|
Oshchepkova E.V., Avalyan A.A., Rogoza A.N., Gorieva S.B., Saidova M.A., Chazova I.E.
|
| Vol 18, No 1 (2021) |
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment |
(Rus)
|
|
Denisova A.R., Solntseva T.D., Sivakova O.A., Chazova I.E.
|
| Vol 5, No 4 (2008) |
Upravlyaemoe lechenie bol'nykh s sakharnym diabetom tipa 2: rezul'taty issledovaniya ADVANCE |
|
|
Karpov Y.A.
|
| Vol 6, No 1 (2009) |
Up-to date view on -blocker in treatment of arterial hypertension with heart failure |
|
|
Gorokhovskaya G.N., Petina M.M., Nikolau E.G., Martynov A.I., Gorohovskaja G.N., Petina M.M., Nikolau E.G., Martynov A.I.
|
| Vol 10, No 2 (2013) |
Use of diuretics in hypertensive patients with metabolic disturbances |
|
|
Zhernakova Y.V., Chazova I.E.
|
| Vol 12, No 4 (2015) |
Using meldonium to improve adaptation of patients with hypertension and pre-diabetes to influence of heat |
(Rus)
|
|
Smirnova M.D., Svirida O.N., Ageev F.T., Fofanova T.V., Vitsenya M.V., Mikhaylov G.V.
|
| Vol 8, No 3 (2011) |
V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii |
|
|
Chazova I.E., Martynyuk T.V., Ratova L.G.
|
| Vol 7, No 4 (2010) |
V kakikh klinicheskikh situatsiyakh tselesoobrazno vybrat' fiksirovannuyu kombinatsiyu -adrenoblokatora i digidropiridinovogoantagonista kal'tsiya v terapii arterial'noy gipertonii. |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 8, No 4 (2011) |
Varianty formirovaniya metabolicheskogo sindroma s pozitsii faktornogo analiza |
|
|
Chernavskiy S.V., Fursov A.N., Potekhin N.P.
|
| Vol 13, No 2 (2016) |
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy |
(Rus)
|
|
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V.
|
| Vol 16, No 4 (2019) |
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity |
(Rus)
|
|
Zheleznova E.A., Zhernakova J.V., Pogorelova O.A., Tripoten M.I., Blinova N.V., Shariya M.A., Azimova M.O., Gorieva S.B., Maslov A.V., Balakhonova T.V., Chazova I.E.
|
| Vol 4, No 1 (2007) |
Vazorenal'naya gipertoniya |
|
|
Grinshteyn Y.I., Shabalin V.V.
|
| Vol 5, No 3 (2008) |
Vedenie zhenshchin s serdechno-sosudistym riskom v peri- i postmenopauze: konsensus rossiyskikh kardiologov i ginekologov |
|
|
Chazova I.E., Smetnik V.P., Balan V.E., Zaydieva Y.Z., Maychuk E.Y., Mychka V.B., Kirichenko A.A., Podzolkov V.I., Podzolkova N.M., Yureneva S.V.
|
| Vol 8, No 4 (2011) |
Vliyanie anomal'noy zhary leta 2010 g. na sostoyanie zdorov'ya kardiologicheskikh bol'nykh i taktika praktikuyushchikh vrachey ambulatorno-poliklinicheskogo zvena (po dannym anketirovaniya 215 vrachey poliklinik Moskvy i Moskovskoy oblasti) |
|
|
Chazova I.E., Ageev F.T., Smirnova M.D., Galaninskiy P.V., Shal'nova S.A.
|
| Vol 7, No 1 (2010) |
Vliyanie antigipertenzivnoy terapii Ko-renitekom na tolshchinu kompleksa intima-media sonnykh arteriy (klinicheskiy primer) |
|
|
Ostroumova O.D., Stepura O.B., Sazonova A.G., Zhukova O.V.
|
| Vol 7, No 2 (2010) |
Vliyanie antigipertenzivnoy terapii Mikardisom Plyus na funktsiyu pochek (klinicheskiy primer) |
|
|
Ratova L.G., Chazova I.E.
|
| Vol 8, No 3 (2011) |
Vliyanie chisla odnovremennovstrechayushchikhsya komponentovmetabolicheskogo sindroma na tyazhest'arterial'noy gipertonii,rasprostranennost' i vyrazhennost'porazheniya organov-misheneyu dannykh bol'nykh |
|
|
Zhernakova Y.V., Chazova I.E.
|
| Vol 1, No 1 (2004) |
Vliyanie gipolipidemicheskoy terapii na insulinorezistentnost' u patsientov s metabolicheskim sindromom |
|
|
Mychka V.B., Chazova I.E.
|
| Vol 7, No 4 (2010) |
Vliyanie kombinirovannoy blokady renin-angiotenzin-al'dosteronovoy sistemy s primeneniem Rasileza i enalaprilana uroven' mikroal'buminurii u bol'nykh gipertonicheskoy bolezn'yu. |
|
|
Kachnov V.A., Kol'tsov A.V., Tyrenko V.V., Nikitin A.E., Sinopal'nikov D.O., Shcherbatyuk O.V., Meshkova M.E., Vetushko V.D.
|
| Vol 7, No 2 (2010) |
Vliyanie preparata Logimaks na uroven' arterial'nogo davleniya, gipertrofiyu miokarda levogo zheludochka, tolshchinu kompleksa intima-media sonnykh arteriy i disfunktsiyu endoteliya u patsientov s essentsial'noy arterial'noy gipertoniey |
|
|
Ostroumova O.D., Zhukova O.V., Vikent'ev V.V., Sazonova A.G., Srednyakov A.V.
|
| Vol 10, No 3 (2013) |
Vliyanie raznykh skhem antigipertenzivnoy terapii s dostizheniem tselevykh znacheniy arterial'nogo davleniya na sostoyanie funktsii pochek i vnutripochechnoe sosudistoe soprotivlenie u bol'nykh sakharnym diabetom tipa 2 |
|
|
Koshel'skaya O.A., Zhuravleva O.A., Karpov R.S.
|
| Vol 7, No 3 (2010) |
Vliyanie SRAR-terapii na «sosudistye» faktory riska serdechno-sosudistykh oslozhneniy u patsientov s tyazhelym sindromom obstruktivnogo apnoe sna i arterial'noy gipertenziey |
|
|
Sukmarova Z.N., Litvin A.Y., Rogoza A.N., Chazova I.E.
|
| Vol 8, No 4 (2011) |
Vliyanie stepeni narusheniy uglevodnogo obmena na tyazhest' arterial'noy gipertonii, rasprostranennost' i vyrazhennost' porazheniya organov-misheney u bol'nykh s metabolicheskim sindromom |
|
|
Zhernakova Y.V., Chazova I.E., Sharipova G.K., Olimpieva S.P., Kilikovskiy V.V.
|
| Vol 2, No 1 (2005) |
Vliyanie terapii bisoprololom i aktoveginom na perfuziyu golovnogo mozga u patsientov s metabolicheskim sindromom |
|
|
Mychka V.B., Chazova I.E., Gornostaev V.V., Sergienko V.B.
|
| Vol 3, No 1 (2006) |
Vliyanie terapii bisoprololom na perfuziyu golovnogo mozga u bol'nykh s metabolicheskim sindromom |
|
|
Mychka V.B., Sergienko V.B., Gornostaev V.V., Dvoskina I.M., Chazova I.E.
|
| Vol 7, No 2 (2010) |
Voprosy effektivnosti i bezopasnosti terapii arterial'noy gipertonii. Diuretiki i β-adrenoblokatory: za i protiv |
|
|
Adasheva T.V., Zadionchenko V.S., Grineva Z.O., Mironova M.A.
|
| Vol 8, No 1 (2011) |
Vospalenie i legochnaya gipertenziya u patsientov s khronicheskoy obstruktivnoy bolezn'yu legkikh. |
|
|
Nakonechnikov S.N., Chazova I.E., Martynyuk T.V., Ratova L.G., Rvacheva A.V., Zykov K.A., Masenko V.P.
|
| Vol 4, No 1 (2007) |
Vozmozhnost' korrektsii Ravelom SR faktorov riska pri arterial'noy gipertenzii na fone ozhireniya |
|
|
Nedogoda S.V., Barykina I.N., Brel' U.A., Chalyabi T.A.
|
| Vol 7, No 1 (2010) |
Vozmozhnosti amlodipina v snizhenii riska oslozhneniy arterial'noy gipertenzii |
|
|
Chazova I.E., Ratova L.G.
|
| 601 - 700 of 734 Items |
<< < 1 2 3 4 5 6 7 8 > >> |
